These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 30024460)

  • 21. Analysis of HSP27 and the Autophagy Marker LC3B
    Livingston JA; Wang WL; Tsai JW; Lazar AJ; Leung CH; Lin H; Advani S; Daw N; Santiago-O'Farrill J; Hollomon M; Gordon NB; Kleinerman ES
    Mol Cancer Ther; 2018 Jun; 17(6):1315-1323. PubMed ID: 29592877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma.
    Li Z; Jia M; Wu X; Cui J; Pan A; Li L
    Diagn Pathol; 2015 Sep; 10():167. PubMed ID: 26377811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
    Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ
    Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
    Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
    Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
    Piperno-Neumann S; Le Deley MC; Rédini F; Pacquement H; Marec-Bérard P; Petit P; Brisse H; Lervat C; Gentet JC; Entz-Werlé N; Italiano A; Corradini N; Bompas E; Penel N; Tabone MD; Gomez-Brouchet A; Guinebretière JM; Mascard E; Gouin F; Chevance A; Bonnet N; Blay JY; Brugières L; ; ;
    Lancet Oncol; 2016 Aug; 17(8):1070-1080. PubMed ID: 27324280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneous necrosis and additional tumor necrosis induced by preoperative chemotherapy for osteosarcoma: a case-control study.
    Song WS; Jeon DG; Cho WH; Kong CB; Cho SH; Lee SY; Lee SY
    J Orthop Sci; 2015 Jan; 20(1):174-9. PubMed ID: 25355661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival, complications and functional outcomes of cemented megaprostheses for high-grade osteosarcoma around the knee.
    Zhang C; Hu J; Zhu K; Cai T; Ma X
    Int Orthop; 2018 Apr; 42(4):927-938. PubMed ID: 29427125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial tumor size predicts histologic response and survival in localized osteosarcoma patients.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
    J Surg Oncol; 2008 Apr; 97(5):456-61. PubMed ID: 18270971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological and prognostic values of fibronectin and integrin αvβ3 expression in primary osteosarcoma.
    Shi K; Wang SL; Shen B; Yu FQ; Weng DF; Lin JH
    World J Surg Oncol; 2019 Jan; 17(1):23. PubMed ID: 30691475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of p53 alterations in human osteosarcoma: a meta analysis.
    Yao D; Cai GH; Chen J; Ling R; Wu SX; Li YP
    Int J Clin Exp Pathol; 2014; 7(10):6725-33. PubMed ID: 25400752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study.
    Boye K; Del Prever AB; Eriksson M; Saeter G; Tienghi A; Lindholm P; Fagioli F; Skjeldal S; Ferrari S; Hall KS
    Pediatr Blood Cancer; 2014 May; 61(5):840-5. PubMed ID: 24254749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of increases in tumor volume after neoadjuvant chemotherapy on the outcome of stage II osteosarcoma regardless of histological response.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jung ST; Jeon DG
    J Orthop Sci; 2009 May; 14(3):292-7. PubMed ID: 19499296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon.
    Abou Ali B; Salman M; Ghanem KM; Boulos F; Haidar R; Saghieh S; Akel S; Muwakkit SA; El-Solh H; Saab R; Tamim H; Abboud MR
    J Glob Oncol; 2019 Apr; 5():1-8. PubMed ID: 30946633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
    Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
    Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities.
    Serra M; Scotlandi K; Reverter-Branchat G; Ferrari S; Manara MC; Benini S; Incaprera M; Bertoni F; Mercuri M; Briccoli A; Bacci G; Picci P
    J Clin Oncol; 2003 Feb; 21(3):536-42. PubMed ID: 12560446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
    Xu M; Xu S; Yu X
    World J Surg Oncol; 2014 Nov; 12():341. PubMed ID: 25391880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases.
    Ward WG; Mikaelian K; Dorey F; Mirra JM; Sassoon A; Holmes EC; Eilber FR; Eckardt JJ
    J Clin Oncol; 1994 Sep; 12(9):1849-58. PubMed ID: 8083708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.
    Longhi A; Bielack SS; Grimer R; Whelan J; Windhager R; Leithner A; Gronchi A; Biau D; Jutte P; Krieg AH; Klenke FM; Grignani G; Donati DM; Capanna R; Casanova J; Gerrand C; Bisogno G; Hecker-Nolting S; De Lisa M; D'Ambrosio L; Willegger M; Scoccianti G; Ferrari S
    Eur J Cancer; 2017 Mar; 74():9-16. PubMed ID: 28167373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
    Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
    J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
    Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
    BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.